By Saumya Joseph (Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest setback in attempts...
Read More(Reuters) – Pfizer Inc said on Friday the European Medicines Agency granted the company a positive recommendation for approval of its treatment for a rare disorder that occurs in patients with cardiomyopathy. The drug,...
Read More
By Kate Kelland LONDON (Reuters) – British drugmaker GSK applied on Friday for a license to...
Read More
By Sangmi Cha SEOUL (Reuters) – South Korean health authorities have found vitamin E...
Read More
By Chad Terhune (Reuters) – A U.S. government watchdog is raising fresh concerns that health...
Read More(Reuters) – Correvio Pharma Corp <CORV.TO> <CORV.O> said on Wednesday it would explore options including a sale, a day after its heart drug failed to win the backing of a panel of experts advising the U.S. Food...
Read More
(Reuters) – A print advertisement of Alkermes Plc’s addiction treatment, Vivitrol, is...
Read More(This October 10 story is refiled to correct spelling to Copperman, from Cooperman, in paragraphs 10-12) By Linda Carroll (Reuters Health) – When frozen embryos are used during in vitro fertilization (IVF), the resulting...
Read More
By Lawrence Hurley WASHINGTON (Reuters) – U.S. Supreme Court justices on Tuesday appeared...
Read MoreBy Dania Nadeem and Saumya Joseph (Reuters) – Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp’s drug to correct irregular rhythm in the upper chambers of the...
Read More
By Lisa Girion and Carl O’Donnell (Reuters) – Johnson & Johnson <JNJ.N>...
Read More
By Matthias Blamont PARIS (Reuters) – Sanofi SA said on Monday it would end its research...
Read More
By Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Monday left in place a...
Read More
By Nate Raymond WASHINGTON (Reuters) – The U.S. Supreme Court on Monday turned away a novel...
Read MoreBy Gus Trompiz and Sybille de La Hamaide PARIS (Reuters) – France’s health and environment agency said on Monday it was banning dozens of glyphosate-based weedkillers, most of the volume of such products sold in...
Read More
By Jonathan Barrett SYDNEY (Reuters) – Volunteers in the New Zealand city of Rotorua are...
Read More
(This Dec. 5 story corrects first paragraph to say growth was slower not declined in previous...
Read More
(Reuters) – The U.S. Food and Drug Administration on Friday approved Amgen Inc’s...
Read More
FRANKFURT (Reuters) – Germany’s Bayer <BAYGn.DE> has agreed with plaintiffs to...
Read MoreBy Saumya Joseph (Reuters) – U.S. Food and Drug Administration staffers reviewing Correvio Pharma Corp’s heart drug said on Friday they did not believe the benefits of the therapy outweighed its risks, sending the...
Read More
